MARCY L'ÉTOILE, France and SHERBROOKE, QC, Jan. 15, 2024 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections..

MARCY L'TOILE，France和SHERBROOKE，QC，2024年1月15日/CNW/-bioMérieux，体外诊断领域的世界领导者，宣布收购LUMED，一家开发临床决策支持系统的软件公司，以帮助医院优化抗菌处方并监测医疗保健相关感染。。

bioMérieux today announced that it has acquired the entire share capital of Canadian innovative software company LUMED, increasing its stake from 16% to 100%. The two companies have been working closely together since 2017. The acquisition of 84% of the capital represents an investment close to 9 million euros..

bioMérieux今天宣布，它已经收购了加拿大创新软件公司LUMED的全部股本，将其股份从16%增加到100%。自2017年以来，两家公司一直密切合作。收购84%的资本意味着近900万欧元的投资。。

Appropriate use of available data is essential for hospitals to provide safe and appropriate patient care, and control pharmacy costs. LUMED's advanced software solutions help ensure that local antimicrobial prescription guidelines are followed and implemented1. It gives healthcare professionals all the varied and relevant information they need to optimize their Antimicrobial Stewardship Programs (ASP) and their Infection Prevention and Control (IPC) programs, to provide better care for their patients, combat AMR and improve Infection Control..

适当使用可用数据对于医院提供安全和适当的患者护理以及控制药房成本至关重要。LUMED的高级软件解决方案有助于确保遵守和实施当地的抗菌处方指南1。它为医疗保健专业人员提供了优化其抗菌管理计划（ASP）和感染预防和控制（IPC）计划所需的所有各种相关信息，以为患者提供更好的护理，对抗AMR并改善感染控制。。

Diagnostic and other vital data generated all along the healthcare pathway, when analyzed by intelligent software, are key in assisting the various health professionals in their decision-making process, to achieve optimal benefits for patients.

当通过智能软件进行分析时，整个医疗保健途径产生的诊断和其他重要数据对于帮助各种卫生专业人员进行决策过程至关重要，以实现患者的最佳利益。

LUMED's solutions are a perfect complement to bioMérieux's comprehensive suite of software solutions: BIOMÉRIEUX VISION SUITE.

LUMED的解决方案是对bioMérieux综合软件解决方案套件的完美补充：bioMérieux VISION suite。

'For bioMérieux, it is essential that we extend the scope of diagnostic testing beyond the laboratory itself. Today, many hospitals around the world are structuring themselves around the major issue of antimicrobial resistance and infection prevention. With LUMED, we provide solutions for antimicrobial stewardship teams to improve their daily workflow.

“对于bioMérieux来说，我们必须将诊断测试的范围扩展到实验室本身之外。今天，世界各地的许多医院正在围绕抗菌素耐药性和感染预防的主要问题进行自我构建。通过LUMED，我们为抗菌管理团队提供解决方案，以改进其日常工作流程。

The software contributes to optimizing the process of care delivery, as well as costs and patient management,' declared Jennifer Zinn, Executive Vice President, Clinical Operations, bioMérieux..

bioMérieux临床运营执行副总裁詹妮弗·津恩（JenniferZinn）表示，该软件有助于优化护理流程，以及成本和患者管理。。

Vincent Nault, Chief Executive Officer, LUMED declared: 'This acquisition marks a significant milestone in our journey. Joining forces with bioMérieux aligns with our commitment to advancing antimicrobial stewardship and infection prevention through our cutting-edge modules—such as APSS and ZINC. We believe that combining LUMED's innovative software solutions with bioMérieux's global reach and expertise in diagnostics will create a powerful synergy.

LUMED首席执行官文森特·诺尔特（VincentNault）宣布：“此次收购标志着我们旅程中的一个重要里程碑。与bioMérieux联手，符合我们通过APSS和ZINC等尖端模块推进抗菌管理和感染预防的承诺。我们相信，将LUMED的创新软件解决方案与bioMérieux的全球影响力和诊断专业知识相结合，将产生强大的协同作用。

Together, we can further enhance patient care, combat antimicrobial resistance, and contribute to the evolution of healthcare practices..

总之，我们可以进一步加强患者护理，对抗抗菌素耐药性，并为医疗保健实践的发展做出贡献。。

The acquisition of LUMED once again illustrates bioMérieux's willingness to grow its Data Analytics portfolio, with continued focus and commitment on antimicrobial stewardship and infection prevention and control. bioMérieux is looking forward to welcoming the LUMED team and start leveraging its global commercial network, to bring LUMED software's benefits to the largest possible number of patients..

收购LUMED再次表明，bioMérieux愿意扩大其数据分析组合，继续专注于抗菌管理和感染预防和控制。bioMérieux期待着欢迎LUMED团队，并开始利用其全球商业网络，为尽可能多的患者带来LUMED软件的好处。。

1 Nault V, Pepin J, Beaudoin M, Perron J, Moutquin JM, Valiquette L. Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay. J Antimicrob Chemother. 2017 Mar 1;72(3):933-940.

1 Nault V，Pepin J，Beaudoin M，Perron J，Moutquin JM，Valiquette L.计算机辅助抗菌药物管理干预对抗菌药物使用和住院时间的持续影响。J Antimicrob Chemother。2017年3月1日；72（3）：933-940。

ABOUT BIOMÉRIEUX VISION SUITE

关于BIOMÉRIEUX VISION SUITE

BIOMÉRIEUX VISION SUITE collects and organizes laboratory and hospital data into insightful and actionable information to support diagnostic and clinical decisions at all stages, from individual patient care to public health surveillance, to combat Antimicrobial Resistance and support Antimicrobial Stewardship.

BIOMÉRIEUX VISION SUITE将实验室和医院数据收集并组织成有见地且可行的信息，以支持从个体患者护理到公共卫生监测的各个阶段的诊断和临床决策，以对抗抗菌素耐药性并支持抗菌素管理。

By providing a comprehensive suite of software products and services that collect, analyze and merge various sources of data, BIOMÉRIEUX VISION SUITE empowers our users to take the right decisions at the right time. Learn more..

通过提供一套全面的软件产品和服务来收集、分析和合并各种数据源，BIOMÉRIEUX VISION suite使我们的用户能够在正确的时间做出正确的决策。了解更多。。

ABOUT BIOMÉRIEUX

关于BIOMÉRIEUX

Pioneering Diagnostics

开创性诊断

A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2022, revenues reached €3.6 billion, with over 90% of sales outside of France.

自1963年以来，bioMérieux一直是体外诊断领域的世界领先者，目前在45个国家拥有业务，并在大型分销商网络的支持下为160多个国家提供服务。2022年，收入达到36亿欧元，占法国以外销售额的90%以上。

bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products..

bioMérieux提供诊断解决方案（系统、试剂、软件和服务），用于确定疾病和污染的来源，以改善患者健康并确保消费者安全。其产品主要用于诊断传染病。它们还用于检测农产品、医药和化妆品中的微生物。。

www.biomerieux.com.

www.biomerieux.com.

SOURCE bioMérieux Canada

资料来源：bioMérieux加拿大